Literature DB >> 10573429

Esophageal varices: current management in children.

F M Karrer1, M R Narkewicz.   

Abstract

The treatment of esophageal variceal hemorrhage is still the subject of some controversy. The main causes of portal hypertension in children are portal vein thrombosis or cirrhosis, most commonly caused by biliary atresia. Many treatment options are available including endoscopic, radiographic, and surgical strategies. In general, children with presinusoidal obstructions have preserved hepatic synthetic function, and, therefore, treatment options include endoscopic strategies or portosystemic shunts, each with advocates. For children with advanced liver disease, liver transplantation offers the only chance for cure, so primary treatment of variceal bleeding should be by endoscopic means or transjugular intrahepatic portosystemic shunt (TIPS). Each modality has specific advantages and disadvantages, and treatment recommendations must therefore be tailored to the individual on a case-by-case basis, largely dependent on the expertise and experience of the health care team.

Entities:  

Mesh:

Year:  1999        PMID: 10573429     DOI: 10.1016/s1055-8586(99)70026-0

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  3 in total

1.  Extrahepatic portal hypertension in children: observations on three surgical procedures.

Authors:  K L N Rao; Anju Goyal; Prema Menon; B R Thapa; K L Narasimhan; S K Chowdhary; R Samujh; J K Mahajan
Journal:  Pediatr Surg Int       Date:  2004-09-04       Impact factor: 1.827

2.  [Contribution of endoscopy in portal hypertension in children: about 68 cases].

Authors:  Mounia Lakhdar Idrissi; Abdeladim Babakhoya; Moustapha Hida
Journal:  Pan Afr Med J       Date:  2012-06-28

3.  [Cavernous transformation of the portal vein in children: about 11 cases].

Authors:  Tadmori Ilham; Lakhdar Idrissi Mounia; Hida Moustapha
Journal:  Pan Afr Med J       Date:  2014-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.